Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

2 min read

Veristat to Attend the MassBio Annual Meeting 2016

1

Join Veristat and other Massachusetts life sciences companies at the MassBio Annual meeting, as they discuss the most critical challenges in bringing new products to market.

 

Annual Meeting Highlights Include:

Keynotes speeches:

Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate

Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics

Remarks from special guests: 

  • Charlie Baker, Governor, Commonwealth of Massachusetts
  • Congressman Richard Neal, Dean of the Mass. Delegation
  • Rachel Kaprielian, HHS Regional Director

Discussion topics to include:

  • Price & Value
  • The 2016 National Landscape
  • Advanced Manufacturing
  • Innovative Pricing Models: The Future is Now
  • The Future of Finance & Capital Markets
  • An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
  • Digital Healthcare
  • Technology in Clinical Trials
  • The Microbiome
  • Immunotherapy in Combination
  • Biosimilars
  • Science in SpaceThe MassBio Annual Meeting focuses on the most critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.

The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.

Annual Meeting Highlights:

Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate

Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics

Featuring remarks from special guests: 

  • Charlie Baker, Governor, Commonwealth of Massachusetts
  • Congressman Richard Neal, Dean of the Mass. Delegation
  • Rachel Kaprielian, HHS Regional Director

Discussions include:

  • Price & Value
  • The 2016 National Landscape
  • Advanced Manufacturing
  • Innovative Pricing Models: The Future is Now
  • The Future of Finance & Capital Markets
  • An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
  • Digital Healthcare
  • Technology in Clinical Trials
  • The Microbiome
  • Immunotherapy in Combination
  • Biosimilars
  • Science in Space

The MassBio Annual Meeting focuses on the most critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.

The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.

Annual Meeting Highlights:

Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate

Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics

Featuring remarks from special guests: 

  • Charlie Baker, Governor, Commonwealth of Massachusetts
  • Congressman Richard Neal, Dean of the Mass. Delegation
  • Rachel Kaprielian, HHS Regional Director

Discussions include:

  • Price & Value
  • The 2016 National Landscape
  • Advanced Manufacturing
  • Innovative Pricing Models: The Future is Now
  • The Future of Finance & Capital Markets
  • An Evolving Paradigm of Drug Discovery - Externalization, Virtualization, De-virtualization, Contract Research & Strategic Partnerships
  • Digital Healthcare
  • Technology in Clinical Trials
  • The Microbiome
  • Immunotherapy in Combination
  • Biosimilars
  • Science in Space

 

Schedule a Meeting with Veristat

Take advantage of the time at the event and schedule a time to meet with Veristat.   We are a full-service CRO that can help guide you through the entire clinical development and regulatory process.   Whether you need help writing your protocol, preparing for your regulatory submissions or need a partner to help bring your product from IND to NDA, look to Veristat for a truly collaborative partnership.

2.png

The Influence of MDR’s Article 117 in the Marketing of Combination Products

The Influence of MDR’s Article 117 in the Marketing of Combination Products

The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as...

Read More
Rolling Review mechanisms and CMAs (Conditional Marketing Authorisations) have made it possible to speed up the approval of treatments against Covid-19

Rolling Review mechanisms and CMAs (Conditional Marketing Authorisations) have made it possible to speed up the approval of treatments against Covid-19

GENESIS BIOMED recently interviewed Xavier Luria, former Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA), and now...

Read More
Timeline Mastery: The Strategic Backbone of Marketing Application Success

Timeline Mastery: The Strategic Backbone of Marketing Application Success

In the intricate dance of preparing marketing applications, the timeline serves as a choreographer, directing countless moving parts into a cohesive...

Read More